RESEARCH-USE BIOSIMILAR ANTIBODY
Mirvetuximab
Antibody-drug conjugate · IgG1
Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research.
TARGETFOLR1
YAntibody-drug conjugate
CATALOGSC-BS-372
CATALOG NUMBERSC-BS-372
MOLECULAR WEIGHTApprox. 145.2 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Mirvetuximab (M9346A) is an anti-FOLR1 (folate receptor 1) monoclonal antibody. Mirvetuximab is the antibody moiety of folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian and other FRα-positive cancer research.
Mirvetuximab is a recombinant research-use antibody directed against FOLR1.